Publications by authors named "Ki-Jun Ryu"

Article Synopsis
  • Anti-cancer peptides, such as those derived from the autocrine motility factor (AMF), show promise in killing cancer cells by disrupting their growth and membranes, but more research on their combined effects with plant-derived drugs is needed.
  • In studies on colorectal cancer (CRC) cell lines, AMF peptides were found to significantly inhibit cell growth, reduce colony formation, and increase the production of reactive oxygen species (ROS).
  • The combination of AMF peptides with glycyrrhetinic acid (GA) from licorice further enhanced anti-cancer effects, indicating potential for effective combined therapies for CRC treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer, particularly triple-negative breast cancer (TNBC), is a serious health issue with a high risk of progression due to aggressive characteristics and poor outcomes.
  • A process called epithelial-mesenchymal transition (EMT) plays a key role in the development of invasive cancer, and the protein Snail is crucial in this process.
  • The study reveals that Snail degradation is controlled by chaperone-mediated autophagy (CMA), rather than the usual proteasomal pathway, suggesting new insights for potential therapies targeting Snail regulation and its implications in breast cancer metastasis.
View Article and Find Full Text PDF

Melanosomes are specific organelles dedicated to melanin synthesis and accumulation in melanocytes. Autophagy is suggestively involved in melanosome degradation, although the potential underlying molecular mechanisms remain elusive. In selective autophagy, autophagy receptors and E3-ligases are the key factors conferring cargo selectivity.

View Article and Find Full Text PDF

Snail is a key regulator of the epithelial-mesenchymal transition (EMT), the key step in the tumorigenesis and metastasis of tumors. Although induction of Snail transcription precedes the induction of EMT, the post-translational regulation of Snail is also important in determining Snail protein levels, stability, and its ability to induce EMT. Several kinases are known to enhance the stability of the Snail protein by preventing its ubiquitination; however, the precise molecular mechanisms by which these kinases prevent Snail ubiquitination remain unclear.

View Article and Find Full Text PDF

Rho GDP dissociation inhibitor 2 (RhoGDI2), a regulator of Rho family GTPase, has been known to promote tumor growth and malignant progression in gastric cancer. We previously showed that RhoGDI2 positively regulates Rac1 activity and Rac1 activation is critical for RhoGDI2-induced gastric cancer cell invasion. In this study, to identify the precise molecular mechanism by which RhoGDI2 activates Rac1 activity, we performed two-hybrid screenings using yeast and found that RhoGDI2 plays an important role in the interaction between Rac1, Filamin A and Rac1 activation in gastric cancer cells.

View Article and Find Full Text PDF

Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays important roles in numerous cellular processes, including cell motility, adhesion, and proliferation, by regulating the activity of Rho GTPases. Its expression is altered in various human cancers and is associated with malignant progression. Here, we show that RhoGDI1 interacts with Cullin 3 (CUL3), a scaffold protein for E3 ubiquitin ligase complexes.

View Article and Find Full Text PDF

Snail is a key regulator of epithelial-mesenchymal transition (EMT), which is a major step in tumor metastasis. Although the induction of Snail transcription precedes EMT, posttranslational regulation, especially phosphorylation of Snail, is critical for determining Snail protein levels or stability, subcellular localization, and the ability to induce EMT. To date, several kinases are known that enhance the stability of Snail by preventing its ubiquitination; however, the molecular mechanism(s) underlying this are still unclear.

View Article and Find Full Text PDF
Article Synopsis
  • RhoGDI2 is a protein that helps stomach cancer cells grow bigger and spread to other parts of the body.
  • It works by changing how cells look and behave, making them more invasive and less connected to each other.
  • By controlling another protein called Snail, RhoGDI2 helps reduce an important cell marker (E-cadherin) that normally keeps cells attached, leading to more aggressive cancer behavior.
View Article and Find Full Text PDF
Article Synopsis
  • RhoGDI2 is a protein linked to tumor growth and cancer spreading in stomach cancer.
  • The study found that RhoGDI2 boosts something called VEGF-C, which helps cancer cells survive and resist treatment.
  • This research suggests that targeting RhoGDI2 could help make chemotherapy work better and reduce the chances that the cancer will spread.
View Article and Find Full Text PDF

Rho GDP dissociation inhibitor 2 (RhoGDI2) promotes tumor growth and malignant progression and enhances chemoresistance of gastric cancer. Recently, we noted an inverse correlation between RhoGDI2 and 14-3-3σ expression, which suggests that 14-3-3σ is a target of gastric cancer metastasis and the chemoresistance-promoting effect of RhoGDI2. Herein, we evaluated whether 14-3-3σ is regulated by RhoGDI2 and is functionally important for the RhoGDI2-induced cisplatin resistance of gastric cancer cells.

View Article and Find Full Text PDF

Rho GDP dissociation inhibitor 2 (RhoGDI2) was initially identified as a regulator of the Rho family of GTPases. Our recent works suggest that RhoGDI2 promotes tumor growth and malignant progression, as well as enhances chemoresistance in gastric cancer. Here, we delineate the mechanism by which RhoGDI2 promotes gastric cancer cell invasion and chemoresistance using two-dimensional gel electrophoresis (2-DE) on proteins derived from a RhoGDI2-overexpressing SNU-484 human gastric cancer cell line and control cells.

View Article and Find Full Text PDF

Rho GDP dissociation inhibitor 2 (RhoGDI2) is a regulator of the Rho family GTPases. Recent work from our laboratory suggests that RhoGDI2 expression potentially enhances resistance to cisplatin as well as promotes tumor growth and malignant progression in gastric cancer. In this study, we demonstrate that phospholipase C-gamma (PLCγ) is required for RhoGDI2-mediated cisplatin resistance and cancer cell invasion in gastric cancer.

View Article and Find Full Text PDF